COMPASS Pathways (CMPS) Research & Development (2021 - 2026)

COMPASS Pathways has disclosed Research & Development across 6 years of filings, most recently posting $26.5 million for Q1 2026.

• In Q1 2026, Research & Development fell 14.25% year-over-year to $26.5 million; the TTM figure through Mar 2026 stood at $114.0 million (down 8.78% YoY), while the FY2025 annual figure was $118.4 million, down 0.51% from the prior year.
• Research & Development declined to $26.5 million in Q1 2026, from $29.9 million in the prior quarter.
• Over the last five years, Research & Development for CMPS reached as high as $32.9 million in Q3 2024 and fell as low as $14.0 million in Q3 2022.
• The 5-year median for Research & Development is $26.5 million (2026), against an average of $24.5 million.
• Annual changes were most pronounced in 2022 — Research & Development soared 123.16% — and 2025, when it decreased 17.02%.
• A 5-year view of Research & Development shows it stood at $19.8 million in 2022, then surged by 37.11% to $27.1 million in 2023, then grew by 18.43% to $32.1 million in 2024, then decreased by 6.95% to $29.9 million in 2025, then slipped by 11.46% to $26.5 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $26.5 million, $29.9 million, and $27.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.